Genetic screen in a large series of patients with primary progressive aphasia

[1]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[2]  L. Petrucelli,et al.  FTDP‐17 with Pick body‐like inclusions associated with a novel tau mutation, p.E372G , 2017, Brain pathology.

[3]  S. Pappatà,et al.  GRN deletion in familial frontotemporal dementia showing association with clinical variability in 3 familial cases , 2017, Neurobiology of Aging.

[4]  R. Petersen,et al.  Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP‐17) due to microtubule‐associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy , 2017, Neuropathology and applied neurobiology.

[5]  B. Ghetti,et al.  Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation , 2017, Movement Disorders.

[6]  D. Geschwind,et al.  A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction , 2017, Brain : a journal of neurology.

[7]  L. Grinberg,et al.  GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil , 2016, Alzheimer disease and associated disorders.

[8]  M. Mesulam,et al.  Aphasic variant of Alzheimer disease , 2016, Neurology.

[9]  Ali Torkamani,et al.  Whole-Genome Sequencing of a Healthy Aging Cohort , 2016, Cell.

[10]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[11]  D. Alkon,et al.  Identification of the PS1 Thr147Ile Variant in a Family with Very Early Onset Dementia and Expressive Aphasia , 2015, Journal of Alzheimer's disease : JAD.

[12]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[13]  J. Duffy,et al.  Dominant Frontotemporal Dementia Mutations in 140 Cases of Primary Progressive Aphasia and Speech Apraxia , 2015, Dementia and Geriatric Cognitive Disorders.

[14]  B. Nordestgaard,et al.  Plasma levels of apolipoprotein E and risk of dementia in the general population , 2015, Annals of neurology.

[15]  D. Michaelson.  APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease , 2014, Alzheimer's & Dementia.

[16]  Sandra Weintraub,et al.  Primary progressive aphasia and the evolving neurology of the language network , 2014, Nature Reviews Neurology.

[17]  M. Filippi,et al.  Clinical and MRI correlates of disease progression in a case of nonfluent/agrammatic variant of primary progressive aphasia due to progranulin (GRN) Cys157LysfsX97 mutation , 2014, Journal of the Neurological Sciences.

[18]  B. Borroni,et al.  Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation , 2014, Neurobiology of Aging.

[19]  S. Sorbi,et al.  Heterozygous TREM2 mutations in frontotemporal dementia , 2014, Neurobiology of Aging.

[20]  C. Geula,et al.  Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. , 2014, Brain : a journal of neurology.

[21]  C. Jack,et al.  Progranulin-associated PiB-negative logopenic primary progressive aphasia , 2014, Journal of Neurology.

[22]  G. Comi,et al.  Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation , 2013, Biological Psychiatry.

[23]  D. Geschwind,et al.  Progranulin mutations as risk factors for Alzheimer disease. , 2013, JAMA neurology.

[24]  J. Molinuevo,et al.  Neuroimaging and Biochemical Markers in the Three Variants of Primary Progressive Aphasia , 2013, Dementia and Geriatric Cognitive Disorders.

[25]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[26]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[27]  L. Petrucelli,et al.  TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. , 2012, Journal of Alzheimer's disease : JAD.

[28]  Michelle K. Lupton,et al.  Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. , 2012, Human molecular genetics.

[29]  D. Neary,et al.  Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. , 2012, Brain : a journal of neurology.

[30]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[31]  N. Bresolin,et al.  A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia , 2011, Alzheimer's & Dementia.

[32]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[33]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[34]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[35]  F. Moreno,et al.  “Frontotemporoparietal” dementia , 2009, Neurology.

[36]  Elena Prieto,et al.  Cortical atrophy and language network reorganization associated with a novel progranulin mutation. , 2009, Cerebral cortex.

[37]  L. Lannfelt,et al.  Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation , 2009, neurogenetics.

[38]  C. Broeckhoven,et al.  Granulin mutations associated with frontotemporal lobar degeneration and related disorders: An update , 2008, Human mutation.

[39]  W. Jagust,et al.  Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia , 2008, Annals of neurology.

[40]  D. Geschwind,et al.  Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis , 2008, PLoS genetics.

[41]  Nancy Johnson,et al.  Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia , 2008, Annals of neurology.

[42]  Julie S Snowden,et al.  Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. , 2008, Brain : a journal of neurology.

[43]  D. Munoz,et al.  Progressive Nonfluent Aphasia Associated With a New Mutation V363I in Tau Gene , 2007, American journal of Alzheimer's disease and other dementias.

[44]  P. Pietrini,et al.  Clinicopathologic features of frontotemporal dementia with Progranulin sequence variation , 2007, Neurology.

[45]  S. Melquist,et al.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. , 2006, Human molecular genetics.

[46]  P. Pietrini,et al.  Characteristics of frontotemporal dementia patients with a Progranulin mutation , 2006, Annals of neurology.

[47]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[48]  Jennifer L. Whitwell,et al.  Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. , 2006, Brain : a journal of neurology.

[49]  Karalyn Patterson,et al.  Clinical and pathological characterization of progressive aphasia , 2006, Annals of neurology.

[50]  J. Neuhaus,et al.  Comparison of family histories in FTLD subtypes and related tauopathies , 2005, Neurology.

[51]  M. Weiner,et al.  Cognition and anatomy in three variants of primary progressive aphasia , 2004, Annals of neurology.

[52]  Richard S. J. Frackowiak,et al.  A voxel‐based morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory , 2000, Annals of neurology.

[53]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[54]  M. Mesulam,et al.  Slowly progressive aphasia without generalized dementia , 1982, Annals of neurology.

[55]  B. Borroni,et al.  Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation. , 2017, Journal of Alzheimer's disease : JAD.

[56]  D. Galimberti,et al.  Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation. , 2016, Journal of Alzheimer's disease : JAD.

[57]  F. Chollet,et al.  A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding. , 2014, Journal of Alzheimer's disease : JAD.

[58]  S. Cappa,et al.  Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9. , 2013, Journal of Alzheimer's disease : JAD.

[59]  S. Cappa,et al.  Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia. , 2013, Journal of Alzheimer's disease : JAD.

[60]  Colin J. Mahoney,et al.  The presenilin 1 P264L mutation presenting as non-fluent/agrammatic primary progressive aphasia. , 2013, Journal of Alzheimer's disease : JAD.

[61]  M. Filippi,et al.  The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype. , 2012, Journal of Alzheimer's disease : JAD.

[62]  S. Cappa,et al.  From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder. , 2011, Journal of Alzheimer's disease : JAD.